UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Rheumatic disease and COVID-19: epidemiology and outcomes

Nature reviews. Rheumatology, 2021-02, Vol.17 (2), p.71-72

2021

Volltextzugriff (PDF)

Ankylosing Spondylitis Disease Activity Score (ASDAS): 2018 update of the nomenclature for disease activity states

Annals of the rheumatic diseases, 2018-10, Vol.77 (10), p.1539-1540

2018

Volltextzugriff (PDF)

Understanding and managing anti-MDA 5 dermatomyositis, including potential COVID-19 mimicry

Rheumatology international, 2021-06, Vol.41 (6), p.1021-1036

2021

Volltextzugriff (PDF)

Risk and prognosis of SARS-CoV-2 infection and vaccination against SARS-CoV-2 in rheumatic and musculoskeletal diseases: a systematic literature review to inform EULAR recommendations

Annals of the rheumatic diseases, 2022-03, Vol.81 (3), p.422-432

2022

Volltextzugriff (PDF)

MRI biomarker assessment of neuromuscular disease progression: a prospective observational cohort study

Lancet neurology, 2016, Vol.15 (1), p.65-77

2016

Volltextzugriff (PDF)

Downregulation of myostatin pathway in neuromuscular diseases may explain challenges of anti-myostatin therapeutic approaches

Nature communications, 2017-11, Vol.8 (1), p.1859-8, Article 1859

2017

Volltextzugriff (PDF)

Data-driven definitions for active and structural MRI lesions in the sacroiliac joint in spondyloarthritis and their predictive utility

Rheumatology (Oxford, England), 2021-10, Vol.60 (10), p.4778-4789

2021

Volltextzugriff (PDF)

Excitatory and inhibitory synapses show a tight subcellular correlation that weakens over development

Cell reports (Cambridge), 2024-07, Vol.43 (7), p.114361, Article 114361

2024

Volltextzugriff (PDF)

Disease specificity of autoantibodies to cytosolic 5′-nucleotidase 1A in sporadic inclusion body myositis versus known autoimmune diseases

Annals of the rheumatic diseases, 2016-04, Vol.75 (4), p.696-701

2016

Volltextzugriff (PDF)

Targeting protein homeostasis in sporadic inclusion body myositis

Science translational medicine, 2016-03, Vol.8 (331), p.331ra41

2016

Volltextzugriff (PDF)

Imaging biomarkers in the idiopathic inflammatory myopathies

Frontiers in neurology, 2023-04, Vol.14, p.1146015-1146015

2023

Volltextzugriff (PDF)

Multi-synaptic boutons are a feature of CA1 hippocampal connections in the stratum oriens

Cell reports (Cambridge), 2023-05, Vol.42 (5), p.112397-112397, Article 112397

2023

Volltextzugriff (PDF)

Recent advances in managing axial spondyloarthritis [version 1; peer review: awaiting peer review]

F1000 research, 2020, Vol.9, p.697

2020

Volltextzugriff (PDF)

Factors influencing the outcomes of non-pharmacological interventions for managing fatigue across the lifespan of people living with musculoskeletal (MSK) conditions: a scoping review protocol

BMJ open, 2024-05, Vol.14 (5), p.e082555-e082555

2024

Volltextzugriff (PDF)

COVID-19-associated arthritis: an emerging new entity?

RMD Open, 2022-09, Vol.8 (2), p.e002026

2022

Volltextzugriff (PDF)

Axial Spondyloarthritis: Mimics and Pitfalls of Imaging Assessment

Frontiers in medicine, 2021-04, Vol.8, p.658538-658538

2021

Volltextzugriff (PDF)

Rare variants in SQSTM1 and VCP genes and risk of sporadic inclusion body myositis

Neurobiology of aging, 2016-11, Vol.47, p.218.e1-218.e9

2016

Volltextzugriff (PDF)

Disease activity measurements and monitoring in psoriatic arthritis and axial spondyloarthritis

Best practice & research. Clinical rheumatology, 2014-10, Vol.28 (5), p.711-728

2014

Volltextzugriff (PDF)

Endorsement of definitions of disease activity states and improvement scores for the Ankylosing Spondylitis Disease Activity Score: results from OMERACT 10

Journal of rheumatology, 2011-07, Vol.38 (7), p.1502-1506

2011

Volltextzugriff (PDF)

Understanding and managing anti-MDA 5 dermatomyositis, including potential COVID-19 mimicry

Rheumatology international, 2021-06, Vol.41 (6), p.1021-1036

2021

Volltextzugriff (PDF)

Inhibition of interleukin-17 in axial spondyloarthritis spectrum

The Lancet (British edition), 2020-01, Vol.395 (10217), p.6-8

Machado, Pedro M

2020

Volltextzugriff (PDF)

Response to: ‘Glucocorticoid-induced relapse of COVID-19 in a patient with sarcoidosis’ by Györfi et al

Annals of the rheumatic diseases, 2021-06, Vol.80 (6), p.e88-e88

2021

Volltextzugriff (PDF)

Achievement of higher thresholds of clinical responses and lower levels of disease activity is associated with improvements in workplace and household productivity in patients with axial spondyloarthritis

Therapeutic advances in musculoskeletal disease, 2023-01, Vol.15, p.1759720X231189079-1759720X231189079

2023

Volltextzugriff (PDF)

EULAR provisional recommendations for the management of rheumatic and musculoskeletal diseases in the context of SARS-CoV-2

Annals of the rheumatic diseases, 2020-07, Vol.79 (7), p.851-858

2020

Volltextzugriff (PDF)

1 – 25 von 1.007

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(892)
Mit Volltextzugriff
(838)

Publikationsform

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(5)
... seit 90 Tagen
(25)

Menü

Weitere Dienste

Einstellungen

Rheumatic disease and COVID-19: epidemiology and outcomes

Ankylosing Spondylitis Disease Activity Score (ASDAS): 2018 update of the nomenclature for disease activity states

Understanding and managing anti-MDA 5 dermatomyositis, including potential COVID-19 mimicry

Risk and prognosis of SARS-CoV-2 infection and vaccination against SARS-CoV-2 in rheumatic and musculoskeletal diseases: a systematic literature review to inform EULAR recommendations

MRI biomarker assessment of neuromuscular disease progression: a prospective observational cohort study

Downregulation of myostatin pathway in neuromuscular diseases may explain challenges of anti-myostatin therapeutic approaches

Data-driven definitions for active and structural MRI lesions in the sacroiliac joint in spondyloarthritis and their predictive utility

Excitatory and inhibitory synapses show a tight subcellular correlation that weakens over development

Disease specificity of autoantibodies to cytosolic 5′-nucleotidase 1A in sporadic inclusion body myositis versus known autoimmune diseases

Targeting protein homeostasis in sporadic inclusion body myositis

Imaging biomarkers in the idiopathic inflammatory myopathies

Multi-synaptic boutons are a feature of CA1 hippocampal connections in the stratum oriens

Recent advances in managing axial spondyloarthritis [version 1; peer review: awaiting peer review]

Factors influencing the outcomes of non-pharmacological interventions for managing fatigue across the lifespan of people living with musculoskeletal (MSK) conditions: a scoping review protocol

COVID-19-associated arthritis: an emerging new entity?

Axial Spondyloarthritis: Mimics and Pitfalls of Imaging Assessment

Rare variants in SQSTM1 and VCP genes and risk of sporadic inclusion body myositis

Disease activity measurements and monitoring in psoriatic arthritis and axial spondyloarthritis

Endorsement of definitions of disease activity states and improvement scores for the Ankylosing Spondylitis Disease Activity Score: results from OMERACT 10

Understanding and managing anti-MDA 5 dermatomyositis, including potential COVID-19 mimicry

Inhibition of interleukin-17 in axial spondyloarthritis spectrum

Response to: ‘Glucocorticoid-induced relapse of COVID-19 in a patient with sarcoidosis’ by Györfi et al

Achievement of higher thresholds of clinical responses and lower levels of disease activity is associated with improvements in workplace and household productivity in patients with axial spondyloarthritis

EULAR provisional recommendations for the management of rheumatic and musculoskeletal diseases in the context of SARS-CoV-2

Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry

Suchergebnisse filtern